share_log

HC Wainwright & Co. Maintains Buy on Travere Therapeutics, Raises Price Target to $19

Moomoo 24/7 ·  Apr 24 14:38

HC Wainwright & Co. analyst Ed Arce maintains Travere Therapeutics (NASDAQ:TVTX) with a Buy and raises the price target from $17 to $19.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment